SavedAdd your journal

Journals / Ege Klinikleri Tıp Dergisi / 2018 / Cilt: 56 - Sayı: 2

Single Center Experience In Transcatheter Aortic Valve Implantation For 8 Years

Transkateter Aort Kapak İmplantasyonu’nda 8 Yıllık Tek Merkez Deneyimi

EMRE ÖZDEMİR
SADIK VOLKAN EMREN
NİHAN KAHYA EREN
MUSTAFA KARACA
CEM NAZLI
MEHMET TOKAÇ
Pages
68–72
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The mean value of systolic pulmonary arterial pressure(sPAB)decreased significantly from 41,1 ± 15,7 mmHg to 33,7 ± 11,2 mmHg after the procedure with p value as 0,006.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Severe aortic stenosis (CAD) is the most common valve disease in advanced age patients [1].
📊
Key Findings & Data:The first successful transcatheter aortic valve implantation (TAVI) procedure was performed successfully by Criber et al. in2002[3].
💡
Conclusion & Impact:The mean value of systolic pulmonary arterial pressure(sPAB)decreased significantly from 41,1 ± 15,7 mmHg to 33,7 ± 11,2 mmHg after the procedure with p value as 0,006.
🔬Design:Research Article
📍Scope:2010-2017 Verileri
⚙️Variables:Domain Parameters

Abstract

Severe aortic stenosis (CAD) is the most common valve disease in advanced age patients [1]. Valvular surgery is a long-standing and well-known treatment option for CAD patients. The first successful transcatheter aortic valve implantation (TAVI) procedure was performed successfully by Criber et al. in2002[3]. After that, it started to be widely applied all over the world. Our study was designed retrospectively on patients who under went to TAVI precedure in İzmir Katip Çelebi University, Atatürk Training and Research Hospital between 2010-2017 October. The 1/3 of patients were female and the 2/3 of patients were female. The mean age was 77.1 ± 7.8 and hypertension was the most common comorbid disease with 82%. The mean value of systolic pulmonary arterial pressure(sPAB)decreased significantly from 41,1 ± 15,7 mmHg to 33,7 ± 11,2 mmHg after the procedure with p value as 0,006.

Özet

İleri yaş hastalar baz alındığında ciddi aort darlığı (CAD), en sık kapak hastalığıdır[1]. CAD hastalarının tedavisinde kapak cerrahisi uzun süredir kullanılan iyi bir tedavi seçeneğidir. İnsanda transkateter aort valf implantasyonu(TAVI) işlemi ilk kez Criber ve arkadaşlarınca 2002 yılında başarılı olarak uyguladı[3]. Bundan sonra tüm dünyada yaygın olarak uygulanmaya başlandı. Çalışmamızda İzmir Katip Çelebi Üniversitesi, Atatürk Eğitim ve Araştırma Hastanesi’nde 2010- 2017 Ekim ayı arasında TAVI işlemi yapılan hastalar retrospektif olarak incelenmiştir. Hastaların 1/3’ü erkek 2/3’ü kadın cinsiyetteydi. Yaş ortalaması 77,1±7,8 olarak saptanmış olup, hipertansiyon %82 ile en sık görülen komorbid hastalıktır. Sistolik pulmoner arter basıncı(sPAB) değeri 41,1±15,7 mmHg işlem öncesi değerden 33,7±11,2 mmHg işlem sonrası değere gerileyerek p:0,006 değeri ile anlamlı olarak azalmıştır.

🔖

Cite This Article

ÖZDEMİR, E., EMREN, S. V., EREN, N. K., KARACA, M., NAZLI, C., TOKAÇ, M. (2018). Single Center Experience In Transcatheter Aortic Valve Implantation For 8 Years. Ege Klinikleri Tıp Dergisi, Cilt: 56 - Sayı: 2, 68–72. https://ajindex.com/articles/153463

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet 368(9540), 1005–1011 (2006)
  2. Ross J, Braunwald E. Aortic stenosis. Circulation 38(1 Suppl.), 61–67 (1968)
  3. Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002;106:3006-8
  4. Osnabrugge RL, Mylotte D, Head SJ et al. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a metaanalysis and modeling study. J. Am. Coll. Cardiol. 62(11), 1002–1012 (2013).
  5. Gurvitch R, Tay EL, Wijesinghe N, et al. Transcatheter aortic valve implantation: lessons from the learning curve of the first 270 high-risk patients. Catheter Cardiovasc Interv. 2011;78(7): 977-984
  6. Genereux P, Head SJ, Van Mieghem NM, et al. Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies. J Am Coll Cardiol. 2012;59(25): 2317-2326
  7. Sinhal A, Altwegg L, Pasupati S, Humphries KH, Allard M, Martin P, et al. Atrioventricular block after transcatheter balloon expandable aortic valve implantation. JACC Cardiovasc Interv 2008;1:305-9
  8. Khawaja MZ, Rajani R, Cook A et al. Permanent pacemaker insertion after CoreValve transcatheter aortic valve implantation: incidenceand contributing factors (the UK CoreValve Collaborative Circulation 123(9), 951–960 (2011)
  9. Kodali SK, Williams MR, Smith CR et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N. Engl. J.Med. 366(18), 1686–1695 (2012)
  10. Abdel-Wahab M, Comberg T, B¨uttner HJ et al. Aortic regurgitation after transcatheter aortic valve implantation with balloon- and self-expandable prostheses: a pooled analysis from a 2-center experience. JACC Cardiovasc. Interv. 7(3), 284–292 (2014) United Kingdom Transcatheter Aortic Valve Implantation) Registry. J. Am. Coll. Cardiol. 58(20), 2130–2138 (2011),
  11. Stortecky S, Wenaweser P, Windecker S. Transcatheter aortic valve implantation and cerebrovascular accidents. EuroIntervention 8(Suppl. Q), Q60–Q69 (2012).
  12. Schewel, Dimitry, Schewel, D., Schewel, J., Martin, J. et al. “Impact of transcatheter aortic valve implantation (TAVI) on pulmonary hyper-tension and clinical outcome in patients with severe aortic valvular sten